Cite
HARVARD Citation
Leavey, P. et al. (2021). Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report. Journal of clinical oncology. 39 (36), pp. 4029-4038. [Online].